Carbon-14 Bioconjugation: Peptides and Antibody-Drug Conjugates

Download attached file

Almac explains how the synergy between their peptide and protein technology and
radiolabeling groups can enable the manufacture of carbon-14 labeled peptides and
antibody-drug conjugates (ADCs) to meet customer requirements.

Download Article to Read More…